Investors Research Corp’s Celgene Corp CELG Stock Holding History

Investors Research Corp’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$30K	–	1150
2019 Q3	$30K	Hold	300	–	–	0.02%	609
2019 Q2	$28K	Hold	300	–	–	0.01%	613
2019 Q1	$28K	Buy	+300	New	+$26.2K	0.01%	601

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Investors Research Corp's CELG Position: Q4 2019 in Review

Investors Research Corp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 300 shares — an estimated $30K sold.

Investors Research Corp first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $30K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Investors Research Corp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Investors Research Corp sold 300 Celgene Corp shares in Q4 2019, an estimated $30K.
Investors Research Corp first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Investors Research Corp's Celgene Corp position peaked at $30K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Investors Research Corp's 13F filing for Q4 2019, filed 11 Feb 2020.